Trillium Asset Management’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
Sell
-25,273
Closed -$413K 190
2014
Q2
$413K Buy
25,273
+485
+2% +$7.02K 0.04% 161
2014
Q1
$390K Buy
24,788
+4,910
+25% +$80K 0.04% 160
2013
Q4
$341K Buy
19,878
+1,229
+7% +$18.9K 0.03% 163
2013
Q3
$246K Buy
18,649
+750
+4% +$8.84K 0.03% 180
2013
Q2
$202K Buy
+17,899
New +$190K 0.02% 168

Other funds holding ANGO

Trillium Asset Management's ANGO Position: Q3 2014 in Review

Trillium Asset Management sold out of AngioDynamics (ANGO) in Q3 2014, closing a stake of 25,273 shares — an estimated $413K sold.

Trillium Asset Management first reported a position in ANGO in Q2 2013 and held it in 5 quarters. The position peaked at $413K in Q2 2014. 105 funds tracked by Wall St. Rank hold ANGO as of Q3 2014.

  • Trillium Asset Management reported no remaining AngioDynamics position as of Q3 2014 after selling out during the quarter.
  • Trillium Asset Management sold 25,273 AngioDynamics shares in Q3 2014, an estimated $413K.
  • Trillium Asset Management first reported a position in AngioDynamics in Q2 2013 and held it in 5 quarters.
  • Trillium Asset Management's AngioDynamics position peaked at $413K in Q2 2014.
  • 105 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2014.

Based on Trillium Asset Management's 13F filing for Q3 2014, filed 21 Oct 2014.